R&D The state of UK drug discovery: the pharmaphorum podcast The UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role of complex cell models were all on the agenda for episode 12 of the
Partner Content Partner Content Chief.AI and Medicines Discovery Catapult awarded funding to... ‘Pay as you go’ Artificial Intelligence
Partner Content Partner Content Precision Medicine Market will surpass USD 96600 million by ... Precision Medicine Market will surpass $96bn by 2024
Partner Content Partner Content Healthcare Artificial Intelligence Market will surge at 41% ... Global Healthcare Artificial Intelligence Market
Views & Analysis Rethinking drug discovery George Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change.
News AZ claims another win for Imfinzi in frontline liver cancer AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
